Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150800
Status:
COMPLETED
Last Update Posted:
2021-08-17
First Post:
2005-09-06
Brief Title:
This Trial Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy Who May Have Benefited From Brivaracetam as Adjunctive Treatment the Opportunity to Receive Open Label Brivaracetam Treatment
Sponsor:
UCB PHARMA Inc US
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
N01199
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB PHARMA Inc US
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None